AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
This collaboration turns kitting into a strategic advantage for sponsors and sites
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Total income for the period stood at Rs. 7101.28 crore
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Diversifying its portfolio to include late-phase antiviral agent
The observations are procedural in nature and will be responded to within the stipulated time
Subscribe To Our Newsletter & Stay Updated